School of Medicine
Showing 1-10 of 25 Results
-
Andrei Iagaru
Professor of Radiology (Nuclear Medicine)
On Leave from 08/05/2024 To 12/13/2024Current Research and Scholarly InterestsCurrent research projects include:
1) PET/MRI and PET/CT for Early Cancer Detection
2) Targeted Radionuclide Therapy
3) Clinical Translation of Novel PET Radiopharmaceuticals; -
David Iberri
Clinical Assistant Professor, Medicine - Hematology
BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.
-
Irogue I Igbinosa
Instructor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioIrogue Igbinosa, MD, is a Maternal-Fetal Medicine physician at Stanford University. She is currently an NIH Women's Reproductive Health Scholar (K12), and her research focus includes iron deficiency anemia in pregnancy, severe maternal morbidity and mortality, and health equity.
She graduated from the University of Houston and earned her medical degree at Baylor College of Medicine. She subsequently completed her residency in Obstetrics and Gynecology Residency at Louisiana State University School of Medicine Baton Rouge. After residency, she was an AAMC-CDC Public Health Policy Fellow able to serve in the CDC Emergency Operations Center and contribute to research for healthcare providers regarding the management of the Zika virus in pregnant persons. She completed her Maternal Fetal Medicine fellowship at Stanford in 2022.
Dr. Igbinosa is passionate about community-engaged approaches to bridge gaps in evidence-based care for birthing communities and collaborates with local and national policy committees to raise awareness for reproductive justice in maternal health. Her motto is to listen first and serve with compassion. -
Debra M. Ikeda, M.D.
Professor of Radiology (Breast Imaging), Emerita
Current Research and Scholarly InterestsMy research interests are mammography positioning, tomosynthesis (DBT) cancer detection and diagnosis, MRI, DWI, MRI-guided breast biopsy, breast cancer recurrence, tattoo/ fiducial/wire localization of axillary lymph nodes, breast cancer and FDG PET-CT imaging, artifical intelligence/deep learning, breast density, density notification legislation, COVID-19 effects on Breast Imaging Centers and personnel
-
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Jennifer Ikle
Adjunct Clinical Assistant Professor, Pediatrics - Endocrinology and Diabetes
Current Research and Scholarly InterestsJen is interested in the genetic factors that lead to abnormal beta-cell function and insulin secretion, causing disorders such as hyperinsulinism and neonatal diabetes. Jen’s current research focus is the use of zebrafish models, combined with genetics and genomics, to understand cellular and molecular mechanisms of glucose metabolism and elucidate previously unknown players involved in the regulation of insulin secretion.
-
iva sikirica ilic
Adjunct Clinical Instructor, Educational Programs and Services (EPS)
BioIva Ilic, MD, is a board certified family physician with extensive experience as a hospitalist. She has a special interest in women's health, small office procedures and preventative care.
In her spare time, she hikes with her husband, and plays the piano. -
Yuki Imaoka
Visiting Assistant Professor, Surgery - Abdominal Transplantation
BioYuki Imaoka, MD, PhD is a physician-scientist specializing in gastrointestinal and transplant surgery, oncology, and immunology, with over a decade of clinical experience. Dr. Imaoka earned his MD from Hiroshima University, Japan, followed by a PhD in Gastroenterological and Transplant Surgery from Hiroshima University's Graduate School of Biomedical and Health Sciences. After completing his clinical training and professional appointments at Hiroshima University Hospital, he joined Stanford University in August 2022 as a Visiting Assistant Professor in the Sasaki Lab, focusing on translational research.
Dr. Imaoka’s clinical expertise includes a Senior Residency in General Surgery and a Clinical Fellowship in Gastroenterological and Transplant Surgery at Hiroshima University Hospital. In his academic roles, particularly as an Assistant Professor in the Department of Gastroenterological and Transplant Surgery, he has contributed to groundbreaking research, including clinical trials investigating liver natural killer (NK) cell therapy.
His PhD research made significant advances in exploring the anti-tumor properties of NK cells, especially in the context of tissue-specific NK cell immunotherapy. This work has the potential to revolutionize treatments for liver diseases, as it pioneers new pathways in cellular immunotherapy. Dr. Imaoka’s translational research seeks to address the unmet needs in liver disease treatment, with a focus on improving patient outcomes through innovative therapeutic approaches. His goal is to continue advancing the field of gastrointestinal surgery and transplantation, driving progress in both research and clinical practice. -
Daniel Imler
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsCurrent Research and Scholarly InterestsI am interested in understanding the impact of smart, agile clinical pathways to drive behavior change among providers.
